Seattle Gummy Company Secures The First (IND) Gummy Drug Approval From FDA
The Pharma Data
OCTOBER 14, 2020
15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312.
Let's personalize your content